Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients

The emergence of the novel SARS-CoV2 virus, proclaimed by the World Health Organization (WHO) as a culpable agent for the pandemic situation, caught the scientific and medical communities off guard. One of the most common complications following pulmonary disease is represented by gastrointestinal (...

Full description

Bibliographic Details
Main Authors: Monika Peshevska-Sekulovska, Irina Boeva, Metodija Sekulovski, Miroslav Zashev, Milena Peruhova
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Gastroenterology Insights
Subjects:
Online Access:https://www.mdpi.com/2036-7422/13/2/21
_version_ 1797487217309908992
author Monika Peshevska-Sekulovska
Irina Boeva
Metodija Sekulovski
Miroslav Zashev
Milena Peruhova
author_facet Monika Peshevska-Sekulovska
Irina Boeva
Metodija Sekulovski
Miroslav Zashev
Milena Peruhova
author_sort Monika Peshevska-Sekulovska
collection DOAJ
description The emergence of the novel SARS-CoV2 virus, proclaimed by the World Health Organization (WHO) as a culpable agent for the pandemic situation, caught the scientific and medical communities off guard. One of the most common complications following pulmonary disease is represented by gastrointestinal (GI) disorders, especially ischemic damage. Inflammation, vasculopathy, immobility, endothelial dysfunction, and a hypercoagulable condition have all been proposed as pathophysiological factors for GI ischemia in these patients. Owing to the COVID-19 effect on a variety of GI conditions, especially ischemic changes, and the high mortality rate, physicians should always keep in mind this complication. They should take a deeper look at clinical and imaging modalities in this cohort of patients so that a proper and time-saving treatment strategy can be applied. Our study aimed to elucidate the thrombogenic mechanism in different GI disorders. Moreover, we analyzed the factors related to necrotic GI changes, by summarizing the already reported data of GI ischemia in COVID-19. To the best of our knowledge, this review is the first to incorporate all GI ischemia cases reported in the literature so far.
first_indexed 2024-03-09T23:44:30Z
format Article
id doaj.art-16452a85a411419fb49c2a3f1cf8d72e
institution Directory Open Access Journal
issn 2036-7414
2036-7422
language English
last_indexed 2024-03-09T23:44:30Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Gastroenterology Insights
spelling doaj.art-16452a85a411419fb49c2a3f1cf8d72e2023-11-23T16:44:51ZengMDPI AGGastroenterology Insights2036-74142036-74222022-06-0113220621710.3390/gastroent13020021Gastrointestinal Ischemia—Stumbling Stone in COVID-19 PatientsMonika Peshevska-Sekulovska0Irina Boeva1Metodija Sekulovski2Miroslav Zashev3Milena Peruhova4University Hospital “Lozenetz”, 1407 Sofia, BulgariaUniversity Hospital “Heart and Brain”, 1172 Burgas, BulgariaUniversity Hospital “Lozenetz”, 1407 Sofia, BulgariaUniversity Hospital “Heart and Brain”, 1172 Burgas, BulgariaUniversity Hospital “Heart and Brain”, 1172 Burgas, BulgariaThe emergence of the novel SARS-CoV2 virus, proclaimed by the World Health Organization (WHO) as a culpable agent for the pandemic situation, caught the scientific and medical communities off guard. One of the most common complications following pulmonary disease is represented by gastrointestinal (GI) disorders, especially ischemic damage. Inflammation, vasculopathy, immobility, endothelial dysfunction, and a hypercoagulable condition have all been proposed as pathophysiological factors for GI ischemia in these patients. Owing to the COVID-19 effect on a variety of GI conditions, especially ischemic changes, and the high mortality rate, physicians should always keep in mind this complication. They should take a deeper look at clinical and imaging modalities in this cohort of patients so that a proper and time-saving treatment strategy can be applied. Our study aimed to elucidate the thrombogenic mechanism in different GI disorders. Moreover, we analyzed the factors related to necrotic GI changes, by summarizing the already reported data of GI ischemia in COVID-19. To the best of our knowledge, this review is the first to incorporate all GI ischemia cases reported in the literature so far.https://www.mdpi.com/2036-7422/13/2/21COVID-19gastrointestinal ischemiaischemic colitisnecrotic esophagitismesenteric thrombosis
spellingShingle Monika Peshevska-Sekulovska
Irina Boeva
Metodija Sekulovski
Miroslav Zashev
Milena Peruhova
Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
Gastroenterology Insights
COVID-19
gastrointestinal ischemia
ischemic colitis
necrotic esophagitis
mesenteric thrombosis
title Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
title_full Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
title_fullStr Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
title_full_unstemmed Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
title_short Gastrointestinal Ischemia—Stumbling Stone in COVID-19 Patients
title_sort gastrointestinal ischemia stumbling stone in covid 19 patients
topic COVID-19
gastrointestinal ischemia
ischemic colitis
necrotic esophagitis
mesenteric thrombosis
url https://www.mdpi.com/2036-7422/13/2/21
work_keys_str_mv AT monikapeshevskasekulovska gastrointestinalischemiastumblingstoneincovid19patients
AT irinaboeva gastrointestinalischemiastumblingstoneincovid19patients
AT metodijasekulovski gastrointestinalischemiastumblingstoneincovid19patients
AT miroslavzashev gastrointestinalischemiastumblingstoneincovid19patients
AT milenaperuhova gastrointestinalischemiastumblingstoneincovid19patients